Market Cap (In USD)
4.33 Million
Revenue (In USD)
-
Net Income (In USD)
-11.95 Million
Avg. Volume
74.59 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.921-3.58
- PE
- -0.96
- EPS
- -1.03
- Beta Value
- -1.515
- ISIN
- CA1850534027
- CUSIP
- -
- CIK
- 1892500
- Shares
- 4383234.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Adi Zuloff-Shani Ph.D.
- Employee Count
- -
- Website
- https://www.clearmindmedicine.com
- Ipo Date
- 2022-11-15
- Details
- Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
More Stocks
-
8188
-
CLIG
-
MEIL
-
NVRVFNovra Technologies Inc.
NVRVF
-
8495
-
VTYB
-
PV1
-
THAFF